Share

Diagnostics Digest

A podcast by CM Life Science

Led by specialist consultant Nathan Sharpe, Diagnostics Digest invites thought leaders to discuss industry insights and the latest news and trends in the diagnostics space.Nathan works across Point-of-Care Diagnostics on
Latest Episode1/18/2023

How Has AI Revolutionised Diagnostics?

Season 2, Ep. 2
In this episode, CM Life Science Business Manager, Nathan Rigby, speaks with Erez Naaman, Co-Founder & CTO at Scopio Labs.Prior to Scopio Labs, Erez was VP of Engineering & Business Development at OrCam, a leading Israeli high-tech start-up. He brings much of his insight from this experience to this discussion, as well as insight into the development of his current business, trends in AI and how he believes this affects the future of healthcare.Scopio Labs uses full-field digital cell morphology to automate the analysis of tens of thousands of cells at a time – far more than any human can quantify, bringing dramatically earlier detection and diagnosis of cancers, infections, and other diseases. This technology expedites patients’ access to better care and life-saving treatments, with a key focus on digitizing microscopy and bringing it to the modern age. By providing access to rapid diagnostic tools for the first time. This system includes uniquely built-in computational power to enable AI at the user's fingertips - saving time, enabling collaboration, improving data safety and reducing the need for expensive hardware.If you're interested in hearing more about Erez and his company, or are fascinated by what AI brings to the future of the space, then be sure to have a listen.To find out more about Nathan and his work in the diagnostic space, get in touch at nathan.rigby@lifesci-cm.com or connect on LinkedIn to chat.
1/18/2023

How Has AI Revolutionised Diagnostics?

Season 2, Ep. 2
In this episode, CM Life Science Business Manager, Nathan Rigby, speaks with Erez Naaman, Co-Founder & CTO at Scopio Labs.Prior to Scopio Labs, Erez was VP of Engineering & Business Development at OrCam, a leading Israeli high-tech start-up. He brings much of his insight from this experience to this discussion, as well as insight into the development of his current business, trends in AI and how he believes this affects the future of healthcare.Scopio Labs uses full-field digital cell morphology to automate the analysis of tens of thousands of cells at a time – far more than any human can quantify, bringing dramatically earlier detection and diagnosis of cancers, infections, and other diseases. This technology expedites patients’ access to better care and life-saving treatments, with a key focus on digitizing microscopy and bringing it to the modern age. By providing access to rapid diagnostic tools for the first time. This system includes uniquely built-in computational power to enable AI at the user's fingertips - saving time, enabling collaboration, improving data safety and reducing the need for expensive hardware.If you're interested in hearing more about Erez and his company, or are fascinated by what AI brings to the future of the space, then be sure to have a listen.To find out more about Nathan and his work in the diagnostic space, get in touch at nathan.rigby@lifesci-cm.com or connect on LinkedIn to chat.
1/10/2023

Diversifying Diagnostics to Make a Difference.

Season 2, Ep. 1
In this episode, Nathan speaks with Richard Acton, former CSO at Cignpost Diagnostics, about transitioning a company from a COVID testing business to a health and wellness business.Cignpost Diagnostics is a leading health and diagnostics company, operating globally to empower and guide people towards living a healthier life. By combining scientific expertise with a relentless focus on people, Cignpost has quickly evolved to become a global leader in COVID-19 screening and health diagnostics, establishing safe, managed environments across a range of sectors, including elite sports, defence, film and TV production, and financial services.Richard has an extensive history growing and accelerating businesses in the point-of-care market, working on R&D, lab operations, quality and clinical functions and plenty more. With experience gaining certification in the space and working to lead scientific operations for a COVID testing company throughout the pandemic sees Richard share exciting insight and knowledge from his time at Cignpost.If you are interesting in learning about all things POC from the perspective of a company at the forefront of innovation who is well versed in diversification and overcoming challenges to create success, then be sure to have a listen.If you'd like to chat some more about the themes in this episode, are keen to feature on a podcast yourself or want to learn more about CM Life Science's services; then please get in touch at nathan.sharpe@lifesci-cm.com or let's connect on LinkedIn.
9/1/2022

Adapting to Survive: Rapid Testing Strategies with COVID's Chief Pathology Advisor.

Season 1, Ep. 3
In this episode of Diagnostics Digest, a CM Life Science series discussing trends and insights into the diagnostics market, I speak with David Wells, Chief Executive Officer of the Institute of Biomedical Science (IBMS).With over 21,000 members in 74 countries, IBMS is the leading professional body for scientists, support staff and students in the field of biomedical science. For over 100 years, it has been dedicated to the promotion, development and delivery of excellence in biomedical science within all aspects of healthcare, and to providing the highest standards of service to patients and the public.We discuss the NHS response to rapid testing, the importance of the IBMS and its members as an organisation and what's to come during its biggest conference. Until June 2021 David led the NHS England and NHS Improvement Pathology consolidation programme, seeking to deliver efficient, high quality and innovative pathology services across England.Now appointed Chief Executive of the IBMS, as an expert advising on policy, strategy and technology deployment, he shares fascinating insights from his experiences at the helm of the biggest healthcare challenge the world has ever seen.If you'd like to chat some more about the themes in this episode, are keen to feature on a podcast yourself or want to learn more about CM Life Science's services; then please drop me a message at nathan.sharpe@lifesci-cm.com or let's connect on LinkedIn.